IVD Medical Adds $19M Ether to Its Treasury, marking a bold move by the Hong Kong-listed healthcare company to position Ethereum (ETH) at the core of its digital asset and tokenization strategy.
The company announced a $19 million (HK$149 million) investment in ETH, which will serve multiple roles across its upcoming ivd.xyz platform, a blockchain-based initiative focused on the tokenization of real-world healthcare assets, including pharmaceutical intellectual property.
Ethereum to Power IVD’s Tokenization Platform and Treasury Strategy
According to a statement shared with CoinDesk, IVD Medical Holdings plans to use Ethereum for:
- On-chain ownership verification of tokenized healthcare assets
- Automated revenue distribution via smart contracts
- Settlement layer for its upcoming stablecoin, IVDD
- Staking and re-staking strategies to generate yield and enhance liquidity
- Compliance and governance across cross-border operations
Chief Strategy Officer Gary Deng described Ethereum as “the world’s most mature smart contract platform,” highlighting its high liquidity and growing institutional support — particularly after the U.S. SEC approved a spot ETH ETF.
More Than a Treasury Asset: ETH as Infrastructure
Unlike other companies simply holding crypto as a treasury reserve, IVD is actively integrating ETH into its business infrastructure. The firm’s ivd.xyz platform will use Ethereum to tokenize healthcare-related real-world assets (RWA), with smart contracts automating settlement, ownership tracking, and revenue flows.
ETH will also back IVD’s IVDD stablecoin, intended to facilitate compliant cross-border transactions within both Hong Kong and U.S. regulatory frameworks. Revenue generated from tokenized asset sales and services will be automatically converted into ETH and stored in the company’s treasury.
Yield-Generating Strategies: Staking and Derivatives
In addition to passive holding, IVD Medical plans to actively deploy its ETH in staking, re-staking, and on-chain derivatives protocols. The move is aimed at maximizing returns, boosting liquidity, and adding downside protection to its crypto treasury operations.
IVD Joins Small but Growing List of Crypto-Treasury Firms in Hong Kong
With this purchase, IVD joins a small but notable group of Hong Kong-listed companies incorporating crypto into their treasury strategies:
- Boyaa Interactive (0434.HK) holds over 3,100 BTC (~$300 million), after converting most of its ETH into Bitcoin.
- Meitu (1357.HK) previously held 31,000 ETH and 940 BTC, though it has since exited those positions.
- Smaller holders include Yuxing InfoTech (8005.HK) with 78 BTC, Moon Inc. (1723.HK) with 18.88 BTC, and Walnut Capital (0905.HK) with 10 BTC.
Strategic Partnership with HashKey Group
IVD Medical’s ETH acquisition comes as part of a broader strategic partnership with HashKey Group, the operator of Hong Kong’s licensed HashKey Exchange. The collaboration will support the development and compliance of IVD’s crypto initiatives, offering infrastructure and regulatory guidance.
Conclusion
IVD Medical Adds $19M Ether to Its Treasury not just as a store of value, but as a foundational element of its healthcare tokenization platform. The investment signals growing institutional interest in Ethereum’s real-world use cases, particularly within the healthcare and finance sectors in Asia.
